MIRM vs RJF · rev $336.1M vs rev $15.91B
Mirum Pharmaceuticals Inc (MIRM) versus RJF (RJF) — a side-by-side from cached financials, not a winner call.
Mirum Pharmaceuticals Inc (MIRM) is a biotechnology company listed on NASDAQ.
RJF (RJF) common stock.
Latest reported MIRM revenue for 2026-06-30 was $336.1M. Net income was -$857.4M. MIRM currently screens at market cap $6.22B.
Latest reported RJF revenue for 2025-09-30 was $15.91B. Net income was $2.13B. Revenue was up 6.6% from 2024-09-30 to 2025-09-30. RJF currently screens at market cap $0.
MIRM currently screens at market cap $6.22B. RJF currently screens at market cap $0.
Not investment advice. Open the MIRM and RJF stock pages for the full models.
Not investment advice.